News & Updates
Filter by Specialty:
Aspirin-statin combo lowers hepatocellular carcinoma incidence
Daily use of aspirin reduces the risk of incident hepatocellular carcinoma (HCC), while the combination of daily aspirin use and statin results in a lower incidence of HCC, which suggests a beneficial interaction, according to a study. In addition, no excess oesophageal variceal haemorrhage (VH) is seen among daily aspirin users compared with nonusers.
Aspirin-statin combo lowers hepatocellular carcinoma incidence
09 Apr 2022SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
SARS-CoV-2 infection during pregnancy or the postpartum period is tied to an increased risk of maternal mortality or serious morbidity due to obstetric complications, a study from the US showed.
SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
08 Apr 2022Mild chronic hypertension in pregnancy: BP-lowering treatment improves outcomes without harm
When it comes to treating mild chronic hypertension during pregnancy, a strategy of lowering blood pressure (BP) below 140/90 mm Hg is preferrable, as it leads to better pregnancy outcomes without increasing the risk of birthing small-for-gestational-age babies when compared with a strategy of reserving treatment only for severe hypertension, according to the open-label Chronic Hypertension and Pregnancy (CHAP) trial.
Mild chronic hypertension in pregnancy: BP-lowering treatment improves outcomes without harm
08 Apr 2022Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
07 Apr 2022Anaphylaxis after COVID mRNA vaccination relatively rare
Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.
Anaphylaxis after COVID mRNA vaccination relatively rare
06 Apr 2022Add-on amantadine lessens “off” episodes in Parkinson’s disease
A delayed release/extended release (DR/ER) formulation of amantadine can help reduce breakthrough symptoms in Parkinson’s disease patients when the effect of levodopa therapy wears off, as shown in a recent study.
Add-on amantadine lessens “off” episodes in Parkinson’s disease
06 Apr 2022Prophylactic anticoagulants, pharmacy oversight lower VTE risk in multiple myeloma
Treatment with a guideline-based thromboprophylaxis in multiple myeloma patients and the addition of pharmacy oversight to risk assessment can help reduce the risk of venous thromboembolism (VTE), suggests a recent study.